{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:09Z","timestamp":1786980489130,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10067-021-05590-1","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T16:02:56Z","timestamp":1611763376000},"page":"2805-2819","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Mycophenolate in idiopathic inflammatory myositis: outcome data of a large South Asian cohort"],"prefix":"10.1007","volume":"40","author":[{"given":"Aswin M.","family":"Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchika","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod","family":"Chebbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish Jacob","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Arvind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijesh","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Rebekah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A. J.","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4904-1511","authenticated-orcid":false,"given":"Debashish","family":"Danda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"5590_CR1","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, Werth VP, Pilkington C, Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Dank\u00f3 K, Dimachkie MM, Feldman BM, Torre IGDL, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinska M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O\u2019Callaghan A, Song YW, Vencovsky J, Ytterberg SR, Miller FW, Rider LG (2017) 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76:1955\u20131964. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"key":"5590_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrrheum.2018.41","volume":"14","author":"IE Lundberg","year":"2018","unstructured":"Lundberg IE, de Visser M, Werth VP (2018) Classification of myositis. Nat Rev Rheumatol 14:269\u2013278. https:\/\/doi.org\/10.1038\/nrrheum.2018.41","journal-title":"Nat Rev Rheumatol"},{"key":"5590_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/01.md.0000109755.65914.5e","volume":"83","author":"K Dank\u00f3","year":"2004","unstructured":"Dank\u00f3 K, Ponyi A, Constantin T, Borgulya G, Szegedi G (2004) Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine (Baltimore) 83:35\u201342. https:\/\/doi.org\/10.1097\/01.md.0000109755.65914.5e","journal-title":"Medicine (Baltimore)"},{"key":"5590_CR4","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1136\/ard.2005.045690","volume":"65","author":"IM Bronner","year":"2006","unstructured":"Bronner IM, van der Meulen MFG, de Visser M, Kalmijn S, van Venrooij WJ, Voskuyl AE, Dinant HJ, Linssen WHJP, Wokke JHJ, Hoogendijk JE (2006) Long-term outcome in polymyositis and dermatomyositis. Ann Rheum Dis 65:1456\u20131461. https:\/\/doi.org\/10.1136\/ard.2005.045690","journal-title":"Ann Rheum Dis"},{"key":"5590_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4103\/0972-2327.74190","volume":"13","author":"KN Ramesha","year":"2010","unstructured":"Ramesha KN, Kuruvilla A, Sarma PS, Radhakrishnan VV (2010) Clinical, electrophysiologic, and histopathologic profile, and outcome in idiopathic inflammatory myositis: an analysis of 68 cases. Ann Indian Acad Neurol 13:250\u2013256. https:\/\/doi.org\/10.4103\/0972-2327.74190","journal-title":"Ann Indian Acad Neurol"},{"key":"5590_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/MJT.0b013e3182987983","volume":"22","author":"T Mathur","year":"2015","unstructured":"Mathur T, Manadan AM, Thiagarajan S, Hota B, Block JA (2015) Corticosteroid monotherapy is usually insufficient treatment for idiopathic inflammatory myopathy. Am J Ther 22:350\u2013354. https:\/\/doi.org\/10.1097\/MJT.0b013e3182987983","journal-title":"Am J Ther"},{"key":"5590_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/joim.12511","volume":"280","author":"CV Oddis","year":"2016","unstructured":"Oddis CV (2016) Update on the pharmacological treatment of adult myositis. J Intern Med 280:63\u201374. https:\/\/doi.org\/10.1111\/joim.12511","journal-title":"J Intern Med"},{"key":"5590_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40674-018-0106-2","volume":"4","author":"S Barsotti","year":"2018","unstructured":"Barsotti S, Lundberg IE (2018) Current treatment for myositis. Curr Treat Options Rheumatol 4:299\u2013315. https:\/\/doi.org\/10.1007\/s40674-018-0106-2","journal-title":"Curr Treat Options Rheumatol"},{"key":"5590_CR9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347. https:\/\/doi.org\/10.1056\/NEJM197502132920706","journal-title":"N Engl J Med"},{"key":"5590_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403\u2013407. https:\/\/doi.org\/10.1056\/NEJM197502202920807","journal-title":"N Engl J Med"},{"key":"5590_CR11","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1378\/chest.10-0180","volume":"138","author":"GR Connors","year":"2010","unstructured":"Connors GR, Christopher-Stine L, Oddis CV, Danoff SK (2010) Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest 138:1464\u20131474. https:\/\/doi.org\/10.1378\/chest.10-0180","journal-title":"Chest"},{"key":"5590_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1590\/s1806-37132011000100015","volume":"37","author":"J Solomon","year":"2011","unstructured":"Solomon J, Swigris JJ, Brown KK (2011) Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol Publicacao Of Soc Bras Pneumol E Tisilogia 37:100\u2013109. https:\/\/doi.org\/10.1590\/s1806-37132011000100015","journal-title":"J Bras Pneumol Publicacao Of Soc Bras Pneumol E Tisilogia"},{"key":"5590_CR13","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/art.1780350502","volume":"35","author":"MC Hochberg","year":"1992","unstructured":"Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35:498\u2013502. https:\/\/doi.org\/10.1002\/art.1780350502","journal-title":"Arthritis Rheum"},{"key":"5590_CR14","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/art.37754","volume":"65","author":"CV Oddis","year":"2013","unstructured":"Oddis CV, Reed AM, Aggarwal R, Rider LG, Ascherman DP, Levesque MC, Barohn RJ, Feldman BM, Harris-Love MO, Koontz DC, Fertig N, Kelley SS, Pryber SL, Miller FW, Rockette HE, and the RIM Study Group (2013) Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum 65:314\u2013324. https:\/\/doi.org\/10.1002\/art.37754","journal-title":"Arthritis Rheum"},{"key":"5590_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s42358-018-0030-z","volume":"58","author":"FHC de Souza","year":"2018","unstructured":"de Souza FHC, Miossi R, de Moraes JCB, Bonf\u00e1 E, Shinjo SK (2018) Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies. Adv Rheumatol 58:31. https:\/\/doi.org\/10.1186\/s42358-018-0030-z","journal-title":"Adv Rheumatol"},{"key":"5590_CR16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/CPM.0000000000000171","volume":"23","author":"LJ Witt","year":"2016","unstructured":"Witt LJ, Curran JJ, Strek ME (2016) The Diagnosis and treatment of antisynthetase syndrome. Clin Pulm Med 23:218\u2013226. https:\/\/doi.org\/10.1097\/CPM.0000000000000171","journal-title":"Clin Pulm Med"},{"key":"5590_CR17","first-page":"188","volume":"32","author":"AL Taborda","year":"2014","unstructured":"Taborda AL, Azevedo P, Isenberg DA (2014) Retrospective analysis of the outcome of patients with idiopathic inflammatory myopathy: a long-term follow-up study. Clin Exp Rheumatol 32:188\u2013193","journal-title":"Clin Exp Rheumatol"},{"key":"5590_CR18","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1007\/s00415-014-7313-z","volume":"261","author":"J van de Vlekkert","year":"2014","unstructured":"van de Vlekkert J, Hoogendijk JE, de Visser M (2014) Long-term follow-up of 62 patients with myositis. J Neurol 261:992\u2013998. https:\/\/doi.org\/10.1007\/s00415-014-7313-z","journal-title":"J Neurol"},{"key":"5590_CR19","doi-asserted-by":"publisher","first-page":"R22","DOI":"10.1186\/ar3704","volume":"14","author":"E Schiopu","year":"2012","unstructured":"Schiopu E, Phillips K, MacDonald PM et al (2012) Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine. Arthritis Res Ther 14:R22. https:\/\/doi.org\/10.1186\/ar3704","journal-title":"Arthritis Res Ther"},{"key":"5590_CR20","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s10067-011-1840-0","volume":"30","author":"K-H Yu","year":"2011","unstructured":"Yu K-H, Wu Y-JJ, Kuo C-F, See LC, Shen YM, Chang HC, Luo SF, Ho HH, Chen IJ (2011) Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases. Clin Rheumatol 30:1595\u20131601. https:\/\/doi.org\/10.1007\/s10067-011-1840-0","journal-title":"Clin Rheumatol"},{"key":"5590_CR21","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.3899\/jrheum.101002","volume":"38","author":"Y Yamasaki","year":"2011","unstructured":"Yamasaki Y, Yamada H, Ohkubo M et al (2011) Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan. J Rheumatol 38:1636\u20131643. https:\/\/doi.org\/10.3899\/jrheum.101002","journal-title":"J Rheumatol"},{"key":"5590_CR22","doi-asserted-by":"publisher","unstructured":"Shu XM, Lu X, Xie Y, Wang GC (2011) Clinical characteristics and favorable long-term outcomes for patients with idiopathic inflammatory myopathies: a retrospective single center study in China. BMC Neurol 11. https:\/\/doi.org\/10.1186\/1471-2377-11-143","DOI":"10.1186\/1471-2377-11-143"},{"key":"5590_CR23","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s10067-010-1465-8","volume":"29","author":"KN Mustafa","year":"2010","unstructured":"Mustafa KN, Dahbour SS (2010) Clinical characteristics and outcomes of patients with idiopathic inflammatory myopathies from Jordan 1996-2009. Clin Rheumatol 29:1381\u20131385. https:\/\/doi.org\/10.1007\/s10067-010-1465-8","journal-title":"Clin Rheumatol"},{"key":"5590_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s10067-005-1164-z","volume":"25","author":"A Airio","year":"2006","unstructured":"Airio A, Kautiainen H, Hakala M (2006) Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol 25:234\u2013239. https:\/\/doi.org\/10.1007\/s10067-005-1164-z","journal-title":"Clin Rheumatol"},{"key":"5590_CR25","first-page":"2230","volume":"28","author":"I Marie","year":"2001","unstructured":"Marie I, Hachulla E, Hatron PY, Hellot MF, Levesque H, Devulder B, Courtois H (2001) Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol 28:2230\u20132237","journal-title":"J Rheumatol"},{"key":"5590_CR26","doi-asserted-by":"publisher","first-page":"e0192491","DOI":"10.1371\/journal.pone.0192491","volume":"13","author":"C Wu","year":"2018","unstructured":"Wu C, Wang Q, He L, Yang E, Zeng X (2018) Hospitalization mortality and associated risk factors in patients with polymyositis and dermatomyositis: a retrospective case-control study. PLoS One 13:e0192491. https:\/\/doi.org\/10.1371\/journal.pone.0192491","journal-title":"PLoS One"},{"key":"5590_CR27","first-page":"417","volume":"31","author":"P-Z Wang","year":"2008","unstructured":"Wang P-Z, Guan J-L, Han X-H (2008) The predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis\/dermatomyositis. Zhonghua Jie He He Hu Xi Za Zhi Zhonghua Jiehe He Huxi Zazhi Chin J Tuberc Respir Dis 31:417\u2013420","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi Zhonghua Jiehe He Huxi Zazhi Chin J Tuberc Respir Dis"},{"key":"5590_CR28","doi-asserted-by":"publisher","first-page":"509354","DOI":"10.1155\/2013\/509354","volume":"2013","author":"P Ungprasert","year":"2013","unstructured":"Ungprasert P, Leeaphorn N, Hosiriluck N, Chaiwatcharayut W, Ammannagari N, Raddatz DA (2013) Clinical features of inflammatory myopathies and their association with malignancy: a systematic review in asian population. ISRN Rheumatol 2013:509354\u2013509357. https:\/\/doi.org\/10.1155\/2013\/509354","journal-title":"ISRN Rheumatol"},{"key":"5590_CR29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0002-9343(93)90148-i","volume":"94","author":"MM Joffe","year":"1993","unstructured":"Joffe MM, Love LA, Leff RL, Fraser DD, Targoff IN, Hicks JE, Plotz PH, Miller FW (1993) Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. Am J Med 94:379\u2013387. https:\/\/doi.org\/10.1016\/0002-9343(93)90148-i","journal-title":"Am J Med"},{"key":"5590_CR30","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","volume":"73","author":"R Aggarwal","year":"2014","unstructured":"Aggarwal R, Cassidy E, Fertig N, Koontz DC, Lucas M, Ascherman DP, Oddis CV (2014) Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis 73:227\u2013232. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201800","journal-title":"Ann Rheum Dis"},{"key":"5590_CR31","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.semarthrit.2011.09.008","volume":"41","author":"I Marie","year":"2012","unstructured":"Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF, Levesque H, Jouen F (2012) Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody. Semin Arthritis Rheum 41:890\u2013899. https:\/\/doi.org\/10.1016\/j.semarthrit.2011.09.008","journal-title":"Semin Arthritis Rheum"},{"key":"5590_CR32","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3899\/jrheum.150844","volume":"43","author":"J Bauhammer","year":"2016","unstructured":"Bauhammer J, Blank N, Max R, Lorenz HM, Wagner U, Krause D, Fiehn C (2016) Rituximab in the treatment of Jo1 antibody-associated antisynthetase syndrome: anti-Ro52 positivity as a marker for severity and treatment response. J Rheumatol 43:1566\u20131574. https:\/\/doi.org\/10.3899\/jrheum.150844","journal-title":"J Rheumatol"},{"key":"5590_CR33","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.nmd.2015.04.013","volume":"25","author":"NE Johnson","year":"2015","unstructured":"Johnson NE, Arnold WD, Hebert D, Gwathmey K, Dimachkie MM, Barohn RJ, McVey AL, Pasnoor M, Amato AA, McDermott MP, Kissel J, Heatwole CR (2015) Disease course and therapeutic approach in dermatomyositis: a four-center retrospective study of 100 patients. Neuromuscul Disord NMD 25:625\u2013631. https:\/\/doi.org\/10.1016\/j.nmd.2015.04.013","journal-title":"Neuromuscul Disord NMD"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05590-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05590-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05590-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T12:11:46Z","timestamp":1623240706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05590-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["5590"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05590-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,27]]},"assertion":[{"value":"12 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional ethics committee approval was obtained. IRB Min No.13239.Part of this manuscript has been published as an abstract in the EULAR 2020 proceeding Nair A, Goel R, Chebbi P et al. AB0596 Predictors, long term clinical and treatment outcomes in south Asian patients with idiopathic inflammatory myositis: a single center study. <i>Annals of the Rheumatic Diseases<\/i> 2020;79:1594-1595","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}